Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 240 for “"GIP"”.
-
The study of the chemical characterization of gastric inhibitory polypeptide (GIP) and the role of GIP in the enteroinsular axis
… thesis were to study the physiological role of GIP in the enteroinsular axis and to chemically characterize a side fraction identified in the purification of GIP. In the physiological studies, the dependency of the insulinotropic action of GIP on the prevailing state of glycaemia was confirmed …
-
Isolation of a murine glucose-dependent insulinotropic polypeptide (GIP) cDNA from a tumor derived cell line (STC₆₋₁₄) and quantification of glucose induced increases in GIP mRNA
… studies include the identification of a murine GIP cDNA and investigations into the role of glucose in the increase of GIP mRNA within this cell line. Sequence analysis revealed a 537 base pair cDNA clone for murine GIP which was found to encode an open reading frame of432 base pairs. From this …
-
Alternative signaling pathways of the glucose-dependent insulinotropic polypeptide (GIP) receptor
Glucose-dependent insulinotropic polypeptide (GIP) regulates pancreatic β -cell function by binding to its cognate Family B, G protein-coupled receptor and elevating intracellular cAMP and Ca2 + . The main rationale for the studies described in this Thesis was that multiple interacting …
-
GLP1 – GIP και βαριατρικές επεμβάσεις. Σύγκριση στην απώλεια βάρους και στις μεταβολικές παραμέτρους
… οι λέξεις-κλειδιά: «BARIATRIC SURGERY», «GLP-1 - GIP», «TIRZEPATIDE», «GLP-1», «WEIGHT LOSS», «BMI» και «METABOLIC PARAMETERS». Επιλέχθηκαν μελέτες σε ασθενείς ηλικίας > 18 ετών, που είχαν δείκτη μάζας σώματος (ΒΜΙ) > 25 kg/m2 και οι οποίοι είχαν υποβληθεί σε μεταβολική επέμβαση ή λάμβαναν τις …
-
Regulation of glucose-dependent insulinotropic polypeptide (GIP) receptor expression in the pancreatic β-cell
Glucose-dependent insulinotropic polypeptide (GIP) is a peptide hormone that is released postprandially from the small intestine and acts to potentiate glucose induced insulin secretion from the pancreatic β-cell. In type 2 diabetes (T2D) there is a decreased responsiveness of the pancreas to GIP. …
-
Structure-function studies of the gastric inhibitory polypeptide/glucose dependent insulinotropic polypeptide (GIP) receptor
… Glucose dependent insulinotropic polypeptide (GIP) is now accepted as the most important incretin and, along with the glucagon-like peptide 1 (GLP-1 (7-36) amide) has therapeutic potential in Non-Insulin Dependent Diabetes Mellitus (NDDDM). In the present study, a rat islet GIP receptor …
-
Οι επιδράσεις των αγωνιστών των υποδοχέων GLP1 και GLP1/GIP στη διαχείριση της παχυσαρκίας
… καθώς και του διπλού αγωνιστή GLP-1/GIP τιρζεπατίδης, στη διαχείριση της παχυσαρκίας. Σκοπός της εργασίας ήταν η διερεύνηση των επιδράσεων των συγκεκριμένων φαρμακευτικών παραγόντων στη ρύθμιση της όρεξης, στον έλεγχο της ενεργειακής πρόσληψης, στη μείωση του σωματικού βάρους και στις …
-
Regulation of pancreatic and gastric endocrine secretion by GIP and GLP-1(7-36) amide
… insulinotropic polypeptide (GIP) and truncated glucagon-like peptide-1 (tGLP-1; GLP-K7-36) and GLP-K7-37)) are capable of both stimulating insulin secretion and inhibiting gastric acid secretion, these being referred to as their incretin and enterogastrone actions, …
-
The Effect of the GLP-1/GIP Receptor Co-agonist, MAR709, on Oral Fentanyl Consumption
… glucose dependent insulinotropic polypeptide (GIP) receptor agonists, primarily used in type II diabetes and obesity treatment, have previously been shown to significantly reduce the intake of various drugs of abuse in preclinical models. The impact of GLP-1/GIP receptor co-agonists on oral …
-
Modulation of insulinotropic hormone bioactivity with a focus on clucose-dependent insulinotropic polipeptide (GIP) and its receptor
… oral glucose are compromised in type 2 diabetes. GIP receptor desensitization and internalization were studied as possible mechanisms for the blunted responsiveness to GIP in the human disease, employing in vitro cellular models. Using clonal insulin producing tumour cells (βTC-3) and rat GIP …
-
Studies on the potential utilization of glucose-dependent insulinotropic polypeptide (GIP) in type 1 and type 2 diabetes
Glucose-dependent insulinotropic polypeptide (GIP) is a peptide hormone that is released from the small intestine in response to a meal and acts to potentiate glucose-induced insulin secretion from the pancreatic β-cell. Recently it has been shown that GIP stimulates β-cell growth, differentiation, …
Page 1 of 12